Search Results

• • 23 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Ethnic density and cancer: A review of the evidence

  Authors:Carolyn Y. Fang and Marilyn TsengFrom:Cancer (Vol. 124, Issue 9) Peer-Reviewed

  May 1, 2018 Report

   Citation Only

• Hepatocellular carcinoma is diagnosed at a later stage in alcoholic patients: Results of a prospective, nationwide study

  Authors:Charlotte E. Costentin, Abbas Mourad, Pierre Lahmek, Xavier Causse, Alexandre Pariente, Herve Hagege, et al.From:Cancer (Vol. 124, Issue 9) Peer-Reviewed

  May 1, 2018 Report

   Citation Only

• Lymphedema in ovarian cancer survivors: Assessing diagnostic methods and the effects of physical activity

  Authors:Neel S. Iyer, Brenda Cartmel, Louis Friedman, Fangyong Li, Yang Zhou, Elizabeth Ercolano, et al.From:Cancer (Vol. 124, Issue 9) Peer-Reviewed

  May 1, 2018 Report

   Citation Only

• High control rates of proton- and carbon-ion-beam treatment with intensity-modulated active raster scanning in 101 patients with skull base chondrosarcoma at the Heidelberg Ion Beam Therapy Center

  Authors:Matthias Mattke, Kira Vogt, Nina Bougatf, Thomas Welzel, Jan Oelmann-Avendano, Henrik Hauswald, et al.From:Cancer (Vol. 124, Issue 9) Peer-Reviewed

  May 1, 2018 Report

   Citation Only

• Smoking cessation drugs alone may not help people to quit

  Author:Carrie PrintzFrom:Cancer (Vol. 124, Issue 9) Peer-Reviewed

  May 1, 2018 Report

   Citation Only

• Screening for human papillomavirus-driven oropharyngeal cancer: Considerations for feasibility and strategies for research

  Authors:Aimee R. Kreimer, Meredith S. Shiels, Carole Fakhry, Mattias Johansson, Michael Pawlita, Paul Brennan, et al.From:Cancer (Vol. 124, Issue 9) Peer-Reviewed

  May 1, 2018 Report

   Citation Only

• Phase 1b study of pasireotide, everolimus, and selective internal radioembolization therapy for unresectable neuroendocrine tumors with hepatic metastases

  Authors:Hyun S. Kim, Walid L. Shaib, Chao Zhang, Ganji Purnachandra Nagaraju, Christina Wu, Olatunji B. Alese, et al.From:Cancer (Vol. 124, Issue 9) Peer-Reviewed

  May 1, 2018 Report

   Citation Only

• Dose-intensified hypofractionated stereotactic body radiation therapy for painful spinal metastases: Results of a phase 2 study

  Authors:Matthias Guckenberger, Reinhart A. Sweeney, Maria Hawkins, Jose Belderbos, Nicolaus Andratschke, Merina Ahmed, et al.From:Cancer (Vol. 124, Issue 9) Peer-Reviewed

  May 1, 2018 Report

   Citation Only

• Clinical and mutational spectrum of highly differentiated, paired box 3: forkhead box protein o1 fusion-negative rhabdomyosarcoma: A report from the Children's Oncology Group

  Authors:Lisa A. Teot, Michaela Schneider, Aaron R. Thorner, Jing Tian, Yueh?Yun Chi, Matthew Ducar, et al.From:Cancer (Vol. 124, Issue 9) Peer-Reviewed

  May 1, 2018 Report

   Citation Only

• Safety profile of avelumab in patients with advanced solid tumors: A pooled analysis of data from the phase 1 JAVELIN solid tumor and phase 2 JAVELIN Merkel 200 clinical trials

  Authors:Karen Kelly, Jeffrey R. Infante, Matthew H. Taylor, Manish R. Patel, Deborah J. Wong, Nicholas Iannotti, et al.From:Cancer (Vol. 124, Issue 9) Peer-Reviewed

  May 1, 2018 Report

   Citation Only

• A statewide program providing colorectal cancer screening to the uninsured of South Carolina

  Authors:Jan M. Eberth, Annie Thibault, Renay Caldwell, Michele J. Josey, Beidi Qiang, Edsel Pena, et al.From:Cancer (Vol. 124, Issue 9) Peer-Reviewed

  May 1, 2018 Article

   Citation Only

• A fluid solution: Scientists explore use of liquid biopsy tests to find cancer DNA

  Author:Carrie PrintzFrom:Cancer (Vol. 124, Issue 9) Peer-Reviewed

  May 1, 2018 Report

   Citation Only

• Randomized phase 2 trial of pemetrexed, pemetrexed/bevacizumab, and pemetrexed/carboplatin/bevacizumab in patients with stage IIIB/IV non-small cell lung cancer and an Eastern Cooperative Oncology Group performance status of 2

  Authors:David R. Spigel, John D. Hainsworth, Mathew J. Joseph, Dianna L. Shipley, M. Kelly Hagan, Dana S. Thompson, et al.From:Cancer (Vol. 124, Issue 9) Peer-Reviewed

  May 1, 2018 Report

   Citation Only

• Fertility preservation options in pediatric and adolescent patients with cancer

  Authors:Karen C. Burns, Holly Hoefgen, Andrew Strine, and Roshni DasguptaFrom:Cancer (Vol. 124, Issue 9) Peer-Reviewed

  May 1, 2018 Report

   Citation Only

• Effect of sorafenib on the outcomes of patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation

  Authors:Li Xuan, Yu Wang, Fen Huang, Erlie Jiang, Lan Deng, Bingyi Wu, et al.From:Cancer (Vol. 124, Issue 9) Peer-Reviewed

  May 1, 2018 Report

   Citation Only

• Decreased early mortality associated with the treatment of acute myeloid leukemia at National Cancer Institute-designated cancer centers in California

  Authors:Gwendolyn Ho, Ted Wun, Lori Muffly, Qian Li, Ann Brunson, Aaron S. Rosenberg, et al.From:Cancer (Vol. 124, Issue 9) Peer-Reviewed

  May 1, 2018 Report

   Citation Only

• Adverse mental health outcomes in a population-based cohort of survivors of childhood cancer

  Authors:Paul C. Nathan, Alex Nachman, Rinku Sutradhar, Paul Kurdyak, Jason D. Pole, Cindy Lau, et al.From:Cancer (Vol. 124, Issue 9) Peer-Reviewed

  May 1, 2018 Report

   Citation Only

• Impact of the affordability of novel agents in patients with multiple myeloma: Real?world data of current clinical practice in Mexico

  Authors:Luz Tarin-Arzaga, Daniela Arredondo-Campos, Victor Martinez-Pacheco, Odra Martinez-Gonzalez, Alba Ramirez-Lopez, Andres Gomez-De Leon, et al.From:Cancer (Vol. 124, Issue 9) Peer-Reviewed

  May 1, 2018 Report

   Citation Only

• Nine-year prostate cancer survival differences between aggressive versus conservative therapy in men with advanced and metastatic prostate cancer

  Authors:Marc A. Dall'Era, Mary J. Lo, Jaclyn Chen, Rosemary Cress, and Ann S. HamiltonFrom:Cancer (Vol. 124, Issue 9) Peer-Reviewed

  May 1, 2018 Report

   Citation Only

• Early-stage breast cancer and employment participation after 2 years of follow-up: A comparison with age-matched controls

  Authors:Christine C. Ekenga, Maria Perez, Julie A. Margenthaler, and Donna B. JeffeFrom:Cancer (Vol. 124, Issue 9) Peer-Reviewed

  May 1, 2018 Report

   Citation Only